Commentary: Greater risk of infective endocarditis after biologic valve replacement: A word of caution before expanding the indications to younger patients

J Thorac Cardiovasc Surg. 2023 Oct;166(4):1069-1070. doi: 10.1016/j.jtcvs.2022.02.035. Epub 2022 Feb 26.

Authors

Michio Yoshitake¹, Ko Bando²

Affiliations

¹ Department of Cardiac Surgery, The Jikei University School of Medicine, Tokyo, Japan.
² Department of Cardiac Surgery, The Jikei University School of Medicine, Tokyo, Japan. Electronic address: kobando@jikei.ac.jp.

PMID: 35337678
DOI: 10.1016/j.jtcvs.2022.02.035

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biological Products*
Endocarditis* / etiology
Endocarditis* / surgery
Endocarditis, Bacterial*
Heart Valve Prosthesis*
Humans

Substances

Biological Products